Commitments and Contingencies - Schedule of Milestone Payments (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2024
USD ($)
| |
| Payment One [Member] | |
| Schedule of Milestone Payments [Line Items] | |
| Milestone | Filing of an Investigational New Drug (or any foreign equivalent) for a Licensed Product |
| Payment | $ 50,000 |
| Payment Two [Member] | |
| Schedule of Milestone Payments [Line Items] | |
| Milestone | Dosing of first patient in a Phase 1 Clinical Trial of a Licensed Product |
| Payment | $ 100,000 |
| Payment Three [Member] | |
| Schedule of Milestone Payments [Line Items] | |
| Milestone | Dosing of first patient in a Phase 2 Clinical Trial of a Licensed Product |
| Payment | $ 250,000 |
| Payment Four [Member] | |
| Schedule of Milestone Payments [Line Items] | |
| Milestone | Receipt of New Drug Application (“NDA”) (or foreign equivalent) approval for a Licensed Product |
| Payment | $ 500,000 |
| Payment Five [Member] | |
| Schedule of Milestone Payments [Line Items] | |
| Milestone | Achievement of First Commercial Sale of Licensed Product |
| Payment | $ 1,000,000 |